THYMIDYLATE SYNTHASE HAPLOTYPE IS ASSOCIATED WITH TUMOR RECURRENCE IN STAGE II AND STAGE III COLON CANCER PATIENTS

摘要

The invention provides compositions and methods for determining the likelihoodof tumor recurrence followingtreatment with 5-FU based adjuvant therapy for Stage II or Stage III coloncancer patients. After determining if a patient is lesslikely to experience tumor recurrence once treated, the invention alsoprovides methods for treating these patients.